HER2-overexpressing gastric/gastroesophageal cancer (GC)paclitaxeltrastuzumabramucirumabevorpaceptevoevo-TRPevo-basedTRP
…(ALX148), a CD47 myeloid checkpoint inhibitor, in patients with HER2-overexpressing gastric/gastroesophageal cancer (GC). JCO. 2025;43:332-332.Ethics Approval The study was conducted i…